文献速递脑血管病

首次卒中幸存者遗传风险与预后:CKB与UKB研究

Genetic Risk and Prognosis of the First Incident Stroke Survivors: Findings from China Kadoorie Biobank and UK Biobank.
PubMed 文献 · Neurology · 2025-06-27

基于中国Kadoorie生物银行(CKB)80,908人与英国生物银行(UKB)380,348人的前瞻性队列,采用整合多基因风险评分(iPRS)与多状态模型分析。结果显示iPRS与卒中幸存者复发卒中及后续冠心病风险相关,但与死亡风险无关联,提示PRS有潜力改善卒中预后评估。

要点

  • iPRS与卒中幸存者复发卒中风险相关,CKB的HR为1.08(1.05-1.11),UKB为1.11(1.03-1.19)。
  • iPRS与卒中后冠心病风险相关,CKB的HR为1.08(1.02-1.15),UKB为1.23(1.10-1.37)。
  • iPRS与卒中后死亡风险无关联,两个队列均未发现显著关联。

核心结论

  • 首次卒中的遗传风险也影响卒中幸存者的预后,提示多基因风险评分有潜力改善卒中预后评估。

研究设计与样本

  • 研究使用中国Kadoorie生物银行(CKB)与英国生物银行(UKB)两个前瞻性人群队列数据。
  • 纳入基线时无卒中且无冠心病的无亲缘关系参与者,CKB共80,908人、UKB共380,348人。
  • 遗传风险采用整合多基因风险评分(iPRS)量化,并用多状态模型分析基线至首次卒中、再至复发卒中、后续冠心病及死亡的转归。

主要发现

  • CKB与UKB中位随访分别为11.9年与13.4年,分别有13,481例与5,772例首次卒中幸存者。
  • 上述幸存者中分别发生5,707例与943例复发卒中,以及1,196例与418例冠心病事件。
  • iPRS每增加1个标准差,复发卒中HR在CKB为1.08(1.05-1.11)、UKB为1.11(1.03-1.19);冠心病HR在CKB为1.08(1.02-1.15)、UKB为1.23(1.10-1.37)。
  • iPRS与死亡风险无关联;将首次卒中分为4种病理亚型后,两个队列均显示iPRS与首次缺血性卒中至复发卒中及冠心病的转归存在统计学显著关联。

关键数值与推荐

  • CKB参与者平均年龄54.0岁、女性占58.6%;UKB平均年龄56.1岁、女性占55.4%。
  • CKB与UKB中位随访分别为11.9年与13.4年。
  • iPRS每增加1个标准差的HR:CKB复发卒中1.08(1.05-1.11)、冠心病1.08(1.02-1.15);UKB复发卒中1.11(1.03-1.19)、冠心病1.23(1.10-1.37)。

临床怎么用

  • 对首次卒中幸存者,可考虑结合多基因风险评分(iPRS)评估复发卒中与后续冠心病风险。
  • iPRS与死亡风险无关联,不宜将其用于卒中后死亡风险分层。

局限性

  • 研究纳入基线无卒中且无冠心病的参与者,结论外推需谨慎。
  • iPRS基于欧洲与东亚人群的汇总统计构建,跨人群适用性需进一步验证。
  • 随访期间事件 ascertainment 与亚型分类可能受队列数据限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Stroke is known for its poor prognosis. Although genetic instruments have shown promise in stratifying first stroke risk in the general population, it is unknown whether they are associated with stroke prognosis. Our study aims to explore the role of genetic risk of stroke in the progression from stroke-free to first stroke and then to recurrent stroke, subsequent coronary heart disease (CHD), and death in China and the United Kingdom. METHODS: We used data from 2 prospective population-based cohorts, China Kadoorie Biobank (CKB) and UK Biobank (UKB). Participants who were unrelated and free of stroke and CHD at baseline were included. Genetic risks of stroke were quantified using integrative polygenic risk scores (iPRSs), which incorporated summary statistics from multiple genome-wide association studies for stroke outcomes and its subtypes, and vascular-risk traits. We used a multistate model to analyze the roles of genetic risk in the transitions from baseline to first incident stroke and then to recurrent stroke, subsequent CHD, and death. RESULTS: Our study included 80,908 CKB participants and 380,348 UKB participants, with mean ages (% female) of 54.0 years (58.6%) and 56.1 years (55.4%). During median follow-ups of 11.9 years and 13.4 years in the CKB and UKB, respectively, 13,481 and 5,772 participants had their first stroke, neither experienced a CHD, or died within 28 days. These survivors had 5,707 and 943 recurrent strokes, as well as 1,196 and 418 CHD events, respectively. iPRSs were associated with recurrent stroke and CHD among stroke survivors in both populations. The corresponding hazard ratios (HRs) and 95% CIs per SD of iPRSs were 1.08 (1.05-1.11) and 1.08 (1.02-1.15) in CKB and 1.11 (1.03-1.19) and 1.23 (1.10-1.37) in UKB, respectively. There was no association between iPRSs and mortality risk. When we further divided the first stroke into 4 pathologic subtypes, both populations revealed statistically significant associations between iPRSs and the transitions from first ischemic stroke to recurrent stroke and CHD. DISCUSSION: Our study shows that the genetic risk of first stroke also influences the prognosis of stroke survivors, indicating that PRS has the potential to improve stroke prognosis.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Han Y, Shi H, Yu C, et al. Genetic Risk and Prognosis of the First Incident Stroke Survivors: Findings from China Kadoorie Biobank and UK Biobank. Neurology. 2025. PMID: 40577674. doi:10.1212/WNL.0000000000213832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。